Literature DB >> 32733108

Autism Spectrum Disorder Screening at 18-36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required?

Birol Karabulut1, Begum Sahbudak1.   

Abstract

Background: Hypoxia, acidosis, and inflammation cause impairment of neuronal development due to lack of sufficient oxygen and nutrition, and there may be an increased risk of ASD in neonates with Neonatal Encephalopathy (NE). To evaluate the frequency of Autism Spectrum Disorder (ASD) in moderate and severe NE requiring therapeutic hypothermia at 18-36 months.
Methods: In this prospective study, infants with moderate and severe NE requiring hypothermia were included.
Results: Throughout the study period, 33 of 85 neonates with NE admitted to our unit were included in the study. M-CHAT results of six infants included in the study showed positive and results of twenty-seven patients were negative. Four of six infants with a positive screening test completed a psychiatric examination, and two infants did not complete the clinical examination. The results of the examination showed that one infant was diagnosed with ASD, one was diagnosed with attention deficit hyperactivity disorder (ADHD), and two infants were diagnosed with no psychiatric disorder.
Conclusion: Our results showed that the risk of ASD increases in infants with moderate and severe NE, and this relationship should be considered in long-term clinical follow-ups.
Copyright © 1964–2019 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.

Entities:  

Keywords:  autism; neonatal encephalopathy; screening

Mesh:

Year:  2020        PMID: 32733108      PMCID: PMC7377542     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  65 in total

1.  Offspring sex and pregnancy outcome by length of gestation.

Authors:  Lars J Vatten; Rolv Skjaerven
Journal:  Early Hum Dev       Date:  2004-01       Impact factor: 2.079

Review 2.  Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis.

Authors:  Hannah Gardener; Donna Spiegelman; Stephen L Buka
Journal:  Pediatrics       Date:  2011-07-11       Impact factor: 7.124

3.  The Modified Checklist for Autism in Toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders.

Authors:  D L Robins; D Fein; M L Barton; J A Green
Journal:  J Autism Dev Disord       Date:  2001-04

Review 4.  Long-term follow-up of term neonates with perinatal asphyxia.

Authors:  C M Robertson; N N Finer
Journal:  Clin Perinatol       Date:  1993-06       Impact factor: 3.430

5.  Maternal and birth risk factors for children screening positive for autism spectrum disorders on M-CHAT-R.

Authors:  Saranya Ravi; Venkatesh Chandrasekaran; Shivanand Kattimani; Mahadevan Subramanian
Journal:  Asian J Psychiatr       Date:  2016-04-23

Review 6.  Hypoxic-ischemic encephalopathy in the term infant.

Authors:  Ali Fatemi; Mary Ann Wilson; Michael V Johnston
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

7.  Neonatal encephalopathy: an inadequate term for hypoxic-ischemic encephalopathy.

Authors:  Joseph J Volpe
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422

8.  Comparison of a broad-based screen versus disorder-specific screen in detecting young children with an autism spectrum disorder.

Authors:  Lisa D Wiggins; Vivian Piazza; Diana L Robins
Journal:  Autism       Date:  2012-12-21

Review 9.  Brain and cognitive-behavioural development after asphyxia at term birth.

Authors:  Michelle de Haan; John S Wyatt; Simon Roth; Faraneh Vargha-Khadem; David Gadian; Mortimer Mishkin
Journal:  Dev Sci       Date:  2006-07

10.  Neonatal outcomes of moderately preterm infants compared to extremely preterm infants.

Authors:  Michele C Walsh; Edward F Bell; Sarah Kandefer; Shampa Saha; Waldemar A Carlo; Carl T D'angio; Abbot R Laptook; Pablo J Sanchez; Barbara J Stoll; Seetha Shankaran; Krisa P Van Meurs; Noah Cook; Rosemary D Higgins; Abhik Das; Nancy S Newman; Kurt Schibler; Barbara Schmidt; C Michael Cotten; Brenda B Poindexter; Kristi L Watterberg; William E Truog
Journal:  Pediatr Res       Date:  2017-05-24       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.